Cargando…
Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs
Immobilized Artificial Membrane (IAM) chromatography columns have been used to model the in vivo distribution of drug discovery compounds. Regis Technologies Inc., the manufacturer, had to replace the silica support and consequently introduced a new IAM.PC.DD2 column that shows slightly different se...
Autores principales: | Valko, Klara, Rava, Silvia, Bunally, Shenaz, Anderson, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association of Physical Chemists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915595/ https://www.ncbi.nlm.nih.gov/pubmed/35299777 http://dx.doi.org/10.5599/admet.757 |
Ejemplares similares
-
Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements
por: Stergiopoulos, Chrysanthos, et al.
Publicado: (2021) -
Affinity of Antifungal Isoxazolo[3,4-b]pyridine-3(1H)-Ones to Phospholipids in Immobilized Artificial Membrane (IAM) Chromatography
por: Ciura, Krzesimir, et al.
Publicado: (2020) -
IAM Chromatographic Models of Skin Permeation
por: Sobańska, Anna W., et al.
Publicado: (2022) -
Biomimetic properties and estimated in vivo distribution of chloroquine and hydroxy-chloroquine enantiomers
por: Valko, Klara L, et al.
Publicado: (2020) -
Trombolisis en el IAM : evaluación y seguimiento a través de una clínica de trombolisis
por: Pizano Salas, Rafael
Publicado: (1999)